Filing Flows › Ingevity (NGVT) › Q2 2026 › vs Q1 2026
Ingevity (NGVT) Q2 2026 vs Q1 2026 (quarter over quarter)
Ingevity's revenue rose $56.1M (+22%) from $258M in Q1 2026 to $314M in Q2 2026. Gross margin 44.3% against 45.1% (-0.9 pts).
Ingevity, Q2 2026: revenue $314M (-5% year over year), operating margin 14.7%, net earnings $35.3M, operating cash flow −$13.8M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Gross margin | 44.3% | 45.1% | -0.9 pts |
| Operating margin | 14.7% | 25.8% | -11.1 pts |
| Net margin | 11.2% | 23.2% | -11.9 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $314M | $258M | $56.1M | +22% |
| Gross profit | $139M | $116M | $22.6M | +19% |
| Cost of revenue | $175M | $142M | $33.5M | +24% |
| Operating profit | $46.2M | $66.6M | −$20.4M | -31% |
| Operating expenses | $92.8M | $49.8M | $43.0M | +86% |
| Pre-tax earnings | $46.2M | $66.6M | −$20.4M | -31% |
| Research & development | $6.1M | $6.7M | −$600K | -9% |
| SG&A | $39.0M | $40.7M | −$1.7M | -4% |
| Other operating costs | $47.7M | $2.4M | $45.3M | 20× |
| Net earnings | $35.3M | $59.8M | −$24.5M | -41% |
| Income tax | $10.9M | $6.8M | $4.1M | +60% |
| Operating cash sources | $75.3M | $89.3M | −$14.0M | -16% |
| Depreciation & amortization | $22.0M | $22.7M | −$700K | -3% |
| Share-based compensation | $4.2M | $4.8M | −$600K | -12% |
| Cash used in operations | $13.8M | $2.0M | $11.8M | +590% |
| Working capital & other | $75.3M | $89.3M | −$14.0M | -16% |
Questions
How much did Ingevity's revenue grow quarter over quarter in Q2 2026?
Ingevity's revenue rose $56.1M (+22%) from $258M in Q1 2026 to $314M in Q2 2026. Gross margin 44.3% against 45.1% (-0.9 pts).